Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 180 of the 182 references it cites were found in a registry or an index.

Managing Alcohol Withdrawal in the Elderly

Abstract

The alcohol withdrawal syndrome is common in elderly individuals who are alcohol dependent and who decrease or stop their alcohol intake. While there have been few clinical studies to directly support or refute the hypothesis that withdrawal symptom severity, delirium and seizures increase with advancing age, several observational studies suggest that adverse functional and cognitive complications during alcohol withdrawal do occur more frequently in elderly patients. Most elderly patients with alcohol withdrawal symptoms should be considered for admission to an inpatient setting for supportive care and management. However, elderly patients with adequate social support and without significant withdrawal symptoms at presentation, comorbid illness or past history of complicated withdrawal may be suitable for outpatient management. Although over 100 drugs have been described for alcohol withdrawal treatment, there have been no studies assessing the efficacy of these drugs specifically in elderly patients. Studies in younger patients support benzodiazepines as the most efficacious therapy for reducing withdrawal symptoms and the incidence of delirium and seizure. While short-acting benzodiazepines, such as oxazepam and lorazepam, may be appropriate for elderly patients given the risk for excessive sedation from long-acting benzodiazepines, they may be less effective in preventing seizures and more prone to produce discontinuation symptoms if not tapered properly. To ensure appropriate benzodiazepine treatment, dose and frequency should be individualised with frequent monitoring, and based on validated alcohol withdrawal severity measures. Selected patients who have a history of severe or complicated withdrawal symptoms may benefit from a fixed schedule of benzodiazepine provided that medication is held for sedation. beta-Blockers, clonidine, carbamazepine and haloperidol may be used as adjunctive agents to treat symptoms not controlled by benzodiazepines. Lastly, the age of the patient should not deter clinicians from helping the patient achieve successful alcohol treatment and rehabilitation.

Overview

Integrity signals

Registry

Crossref · 10.2165/00002512-199914060-00002

Cites

180 of 180 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 182 references

Cited by

See all 56

Metadata

Authors
Kraemer, K. L., Conigliaro, J., & Saitz, R.
Affiliations
  • University of Pittsburgh (US)
  • VA Pittsburgh Healthcare System (US)
  • Boston University (US)
Venue
Drugs & Aging
Published
1999
Volume
14
Issue
6
Pages
409-425
ISSN
1170-229X (ISSN-L)
OpenAlex
W2012079123
Cited by
53
References
182
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 1 · 2017: 3 · 2016: 2 · 2015: 4 · 2014: 5 · 2012: 3
FWCI
1.25
Type
journal article
Language
en
Open access
closed
Locations
  • Drugs & Aging (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5k08aa000235-02)
  • National Institute on Alcohol Abuse and Alcoholism (R01AA010870, 5R01-AA10870, 5K08-AA00235)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Alcoholism and Thiamine Deficiency
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Keywords
alcohol withdrawal, elderly patients, alcoholism, benzodiazepines, withdrawal seizures, oxazepam, lorazepam, sedation, benzodiazepine tapering, beta-blockers, clonidine, carbamazepine, haloperidol, outpatient management, hospitalization, alcohol rehabilitation
MeSH terms
Age Factors, Aged, Alcoholism, Clinical Trials as Topic, Humans, Substance Withdrawal Syndrome, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Managing Alcohol Withdrawal in the Elderly. https://app.cochat.ai/papers/10.2165/00002512-199914060-00002
The paper
Kraemer, K. L., Conigliaro, J., & Saitz, R. (1999). Managing Alcohol Withdrawal in the Elderly. Drugs & Aging. https://doi.org/10.2165/00002512-199914060-00002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.